Majority of B.C. women take prescription drugs during pregnancy: study

December 15, 2011 in Health

Almost two-thirds of women in British Columbia filled at least one prescription at some point in their pregnancy, including drugs with potential risks, according to a new study by University of British Columbia researchers.

The study, published today in the journal Clinical Therapeutics, is the first of its kind in . Researchers analyzed population-based outpatient prescription claims data for patterns of prescription during in B.C. from 2001 to 2006.

The researchers found that 63.5 per cent of in B.C. filled at least one prescription. One in thirteen – or 7.8 per cent – filled a prescription for a medicine known to be risky in pregnancy – most often for select medicines for anxiety, insomnia and depression. Drugs that are strictly contraindicated pregnancy, however, were filled in less than 0.5% of pregnancies.

"Although much remains to be understood about the appropriateness of medicine use that actually occurs among pregnant women in B.C., one encouraging finding from our study is that existing use of medicines with known risks declines dramatically when women become pregnant," says co-author Steve Morgan, an associate professor in the School of Population and Public Health (SPPH) and Associate Director of the Centre for Health Services and Policy Research (CHSPR).

On average, pregnant women filled 2.6 different types of drugs, while 15 per cent used five or more prescription medications during their pregnancy. Prescriptions most frequently filled during pregnancy were for antibiotics (30.5 per cent), respiratory drugs (25.7 per cent), dermatologics (13.4 per cent), and drugs that act on the nervous system (12.8 per cent).

Other study findings include:

  • The use of medicines in pregnancy slightly increased over time, going from 63 per cent of women in 2001 to 66 per cent in 2006.
  • Women aged 20 years or younger were most likely to take during pregnancy (69 per cent) while the lowest rate occurred among those aged 30 to 35 years (62 per cent).
  • Prescription medication use was also high in the first three months immediately following delivery, a period when women may be breastfeeding, with 61.3 per cent of women filling .
"Since pregnant women are normally excluded from clinical trials of new drugs and post-market study is limited, there is little evidence on the risks and benefits of many of the most commonly used drugs in pregnancy," says lead author Jamie Daw, a researcher at CHSPR, part of SPPH. "Given the prevalence of prescription use, more research is needed to help pregnant women and their physicians make informed decisions."

More information: www.clinicaltherapeutics.com

Provided by University of British Columbia search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Pre-proceedings process fails to reduce length of care proceedings, but can help divert cases from court

A major new report on a procedure that aims to reduce the duration of care proceedings for children has found it made no significant difference to what happened in court, and cases lasted just as long regardless of whether ...

Health created 1 hour ago | popularity not rated yet | comments 0

Report reveals impact of public injecting

New research undertaken on the streets of Richmond and Abbotsford has revealed increasing health risks for people who inject drugs and significant community concern over the impact of injecting in public ...

Health created 1 hour ago | popularity not rated yet | comments 0

Consumer group flags high SPF ratings on sunscreen

(AP)—Sunbathers this summer will find new sunscreen labels that are designed to make the products more effective and easier to use.

Health created 4 hours ago | popularity not rated yet | comments 0

ER docs are key to reducing health care costs

Emergency physicians are key decisionmakers for nearly half of all hospital admissions, highlighting a critical role they can play in reducing health care costs, according to a new report from the RAND Corporation.

Health created 6 hours ago | popularity not rated yet | comments 0

New research identifies risks, interventions for children's GI health

An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).

Health created May 18, 2013 | popularity not rated yet | comments 0 | with audio podcast


Neurons that can multitask greatly enhance the brain's computational power, study finds

Over the past few decades, neuroscientists have made much progress in mapping the brain by deciphering the functions of individual neurons that perform very specific tasks, such as recognizing the location ...

Team finds mechanism linking key inflammatory marker to cancer

In a new study described in the journal Oncogene, researchers reveal how a key player in cell growth, immunity and the inflammatory response can be transformed into a primary contributor to tumor growth.

New study identifies risk factors for depression among COPD patients

Patients suffering from chronic obstructive pulmonary disease (COPD) typically suffer from depression more frequently than those without COPD, resulting in higher levels of disability and illness and increasing the overall ...

Youth bullying because of perceived sexual orientation widespread and damaging

(Medical Xpress)—Bullying because of perceived sexual orientation is prevalent among school-aged youths, according to a study led by Donald Patrick, professor of health services at the UW School of Public ...

Inflammatory bowel disease raises risk of melanoma

Patients with inflammatory bowel disease (IBD) are at higher risk of melanoma, a form of skin cancer, report researchers at Mayo Clinic. Researchers found that IBD is associated with a 37 percent greater risk for the disease. ...

Pharmaceutical advances offer new options for health outcomes

Research presented at Digestive Disease Week (DDW) explores pharmaceutical advances for treating irritable bowel syndrome with diarrhea (IBS-D) and hepatitis C.